Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
46.21
+3.90 (9.22%)
Jul 28, 2026, 2:37 PM EDT - Market open
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Eton Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $54.75. The average 1-year stock price forecast is 18.48% higher than the current stock price, while the lowest is $40 (-13.44%) and the highest is $62 (+34.17%).
Price Target: $54.75 (+18.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $40 → $62 | Buy | Maintains | $40 → $62 | +34.17% | Jul 28, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $60 | Buy | Initiates | $60 | +29.84% | Jul 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $57 | Buy | Reiterates | $57 | +23.35% | Jul 1, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $40 | Buy | Reiterates | $40 | -13.44% | Jun 26, 2026 |
Financial Forecast
Revenue This Year
121.09M
from 79.95M
Increased by 51.45%
Revenue Next Year
184.40M
from 121.09M
Increased by 52.29%
EPS This Year
1.05
from 0.32
Increased by 226.56%
EPS Next Year
2.14
from 1.05
Increased by 104.78%
EPS and Forward PE are based on non-GAAP adjusted numbers.